Arthritis is a common complaint among many people, most commonly the elderly, but it can affect younger people as well. There may be different types of arthritis but generally, arthritis involves pain, swelling or stiffness of the joints. Although there are medicines for this condition, it is helpful however to find some natural treatment for arthritis, which can at least help you avoid some side effects of medications. Of course, you can do something about your arthritis. The first thing you can do is to know everything you can about the disease. As mentioned, there are different types of this disease and one of the most common types is the rheumatoid arthritis, which often affects the lining of the joints in the hands and feet that causes the swelling and the pain.
Arthritis in itself is an autoimmune type of disease. One of these autoimmune varieties is Psoriasis. Psoriasis can be defined as one of those skin diseases where particular type of cells in our skin starts growing at a much faster rate. This skin growth, which is actually out of control, can cause the formation of scale like areas on patches of skin. This formation is mainly due to the collection of the dying cells in those areas. This portion of the skin starts flaking off once the cells begin to shed. Doctors have found out that Psoriasis can be tagged as one of the autoimmune diseases where your own body starts to react against the organ, which in this case is the skin.
It is one of the diseases having a painful effect. It has a far-reaching impact on most people who either have themselves or their family members affected by this disease. Literally Arthritis is a term given to joint inflammation. However in the biological world this term is used for hundreds of diseases. These diseases can affect your ligaments muscles tendons and bones causing stiffness, swelling and massive pain. Rheumatoid arthritis and osteoarthritis are the common types of this disease. When the diseases takes place on the common joint causing degenerative effect the arthritis is known as osteoarthritis. This is a common type of arthritis and has already affected more than 20 million of US population.
Rheumatoid arthritis is a disorder that affects a lot of organs and tissues. But it majorly causes problem for the joints and results in inflammatory synovitis. Further, it may also destruct the articular cartilage. The rheumatoid arthritis could also cause inflammations to various parts such as sclera, pleura, lungs and pericardium. Till today, the reason behind this problem has not been discovered. According to a study almost 1% of the population gets affected by this problem and the increase in the women being affected is almost 3 times more than men. You will find people suffering with this problem at the age of 40 to 50. It is a very painful problem, you lose your mobility because of his problem.
When you first find out that you have arthritis you may, like most people, feel a bit dismayed and then relieved that at last there is a name to give your symptoms and that there is a confirmation that they are very real and not in your head and that there is a hoped for treatment. Then reality sets in and you realize that this will effect your life from now on. You experience anger and anxiety to depression and loneliness and then to make matters worse you start to feel guilty because you think you're a wimp for even having those thoughts. Most mental health experts say that it is the rule instead of the exception to having such strong emotions when it comes to being diagnosed with a chronic condition.
ChemoCentryx, Inc. announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA). CCX354 is a highly potent and selective antagonist of CCR1, a chemokine receptor that drives the recruitment of immune cells, such as monocytes and macrophages, associated with the inflammation underlying certain autoimmune diseases, including RA. By selectively blocking the CCR1 receptor, CCX354 is designed to reduce the infiltration of inflammatory cells into the joints of RA patients and inhibiting the subsequent joint destruction while minimizing the potential for off-target effects, thus providing a wider therapeutic window than currently approved therapies.